Cargando…
Comparison of Chromogenic In Situ Hybridisation with Fluorescence In Situ Hybridisation and Immunohistochemistry for the Assessment of Her-2/neu Oncogene in Archival Material of Breast Carcinoma
The successful treatment of breast cancer is dependent upon a number of complex factors. Her-2/neu gene amplification is known to be one of the most common genetic alterations associated with breast cancer and its accurate determination has become necessary for the selection of patients for trastuzu...
Autores principales: | Pothos, Alexios, Plastira, Konstantina, Plastiras, Aris, Vlachodimitropoulos, Dimitrios, Goutas, Nikolaos, Angelopoulou, Roxani |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Histochemistry and Cytochemistry
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447915/ https://www.ncbi.nlm.nih.gov/pubmed/18636112 http://dx.doi.org/10.1267/ahc.07029 |
Ejemplares similares
-
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007) -
Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014) -
Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer
por: Arnould, L, et al.
Publicado: (2003) -
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
por: van de Vijver, Marc, et al.
Publicado: (2007) -
Handbook of immunohistochemistry and in situ hybridisation of human carcinomas: molecular genetics – lung and breast carcinomas
por: Gatter, K C
Publicado: (2005)